Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-21-001342)

Filing Details

Accession Number:: 0001567619-21-001342
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-21 17:06:18
Reporting Period:: 2021-01-19

Accepted Time:: 2021-01-21 17:06:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1656634	Gritstone Oncology Inc.	GRTS	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754293	Roman Yelensky	C/O Gritstone Oncology, Inc. 5959 Horton Street, Suite 300 Emeryville CA 94608	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-01-19	10,000	$22.10	133,224	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $22.00 to $22.40 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.